Sermonix Pharmaceuticals Company

Sermonix Pharmaceuticals Inc is a privately held, Ohio-based biopharmaceutical company with a precision medicine focus for bringing targeted oncology products through development, approval, and commercialization. Sermonix’s lead candidate is oral lasofoxifene.

Total Funding: $67,550,000
Headquarters: Columbus, Ohio, United States
Funding Status: Early Stage Venture
Employee Number: 1-10
Estimated Revenue: $10M to $50M
Last Funding Type: Series A
Last Funding Date: 2021-11-15
Investors Number: 5
Founded Date: 01-01-2014
Industry: Longevity